Psychedelics Heroic psilocybin dose has remarkable impact on Alzheimer’s patient Incredibly, she regained her ability to talk, memory and bladder control after the experience Rowan DunneJune 9, 2026
Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026
Psychedelics UK capital hosts 24-hour psychedelic treadmill race in abandoned tank factory "AP4 is an attempt to create the wildest endurance project ever conceived in London," the organizers say Rowan DunneMay 12, 2026
Psychedelics Louis Vuitton’s new psychedelic wristwatch turns heads The French luxury brand started taking an interest in watches in the early 2000s Rowan DunneApril 9, 2026
Psychedelics Psychedelic music exhibit to captivate Detroit residents in April It will explore the ‘Motown psychedelic soul era’ from 1967 to 1975 Rowan DunneMarch 31, 2026
Psychedelics Deutsche Bank initiates bullish coverage of psychedelics company AtaiBeckley The financial institution has given the drug developer a Buy rating a US$12 share target Rowan DunneMarch 31, 2026
Psychedelics Psychedelic film series continues at Berkeley art museum until May 10 'Psychedelia & Cinema' is organized in partnership with the UC Berkeley Center for the Science of Psychedelics Rowan DunneMarch 19, 2026
Psychedelics Healing Hearts awards over half a million for end-of-life psychedelic therapy The grants focus on providing psilocybin and ketamine in conjunction with standard support Rowan DunneJanuary 30, 2026
Psychedelics New Jersey hops on the medical psilocybin therapy train New legislation is allocating US$6 million toward pilot studies in 3 state hospitals Rowan DunneJanuary 22, 2026
Psychedelics ‘Psychedelic’ tarantula added to Fauna & Flora’s endangered species list The neon-coloured Indian spider is being threatened by habitat loss and the illicit pet trade Rowan DunneJanuary 7, 2026